Amedisys (NASDAQ:AMED) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Amedisys (NASDAQ:AMEDGet Free Report) released its quarterly earnings results on Wednesday. The health services provider reported $1.03 earnings per share for the quarter, topping analysts’ consensus estimates of $1.02 by $0.01, Briefing.com reports. Amedisys had a negative net margin of 0.91% and a positive return on equity of 13.00%. The business had revenue of $571.41 million during the quarter, compared to the consensus estimate of $565.38 million. During the same quarter last year, the company earned $1.00 earnings per share. The business’s quarterly revenue was up 2.7% compared to the same quarter last year.

Amedisys Stock Performance

AMED stock opened at $91.16 on Friday. Amedisys has a 1 year low of $73.10 and a 1 year high of $96.44. The company has a fifty day simple moving average of $92.57 and a 200 day simple moving average of $93.35. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.32.

Wall Street Analyst Weigh In

A number of research analysts have commented on AMED shares. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $101.00 target price on shares of Amedisys in a report on Thursday. StockNews.com started coverage on Amedisys in a research note on Monday, April 8th. They set a “buy” rating on the stock. Raymond James reaffirmed a “market perform” rating on shares of Amedisys in a report on Tuesday, March 26th. Finally, Royal Bank of Canada upped their price objective on shares of Amedisys from $97.00 to $100.00 and gave the company an “outperform” rating in a research note on Monday, March 25th. Seven analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $97.50.

Get Our Latest Research Report on AMED

About Amedisys

(Get Free Report)

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.

See Also

Earnings History for Amedisys (NASDAQ:AMED)

Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.